Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03147196
Title Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

prostate adenocarcinoma

Therapies

Bicalutamide + Raloxifene

Raloxifene

Bicalutamide

Age Groups: adult | senior
Covered Countries


No variant requirements are available.